The team is the first in Canada to receive Horizon Europe funding, leading a project to improve post-hospital care for sepsis. A team led by UBC’s Dr. Matthew Wiens is… Read More
Montreal, QC – OdysseaBio announced an expansion of its strategic scientific communication services to help biotech, pharmaceutical, and life sciences teams translate complex evidence into clear, credible, and decision-ready messaging. The… Read More
U.S.-based cell therapy manufacturing pioneer expands production capacity for European patients with new facility in Leiden. Cellares, the first Integrated Development and Manufacturing Organization (IDMO) for cell therapies headquartered in… Read More
New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT FASPRO™ beyond lung cancer RARITAN, N.J. – Johnson & Johnson announced… Read More
KIRKLAND, Quebec – Merck, known as MSD outside of the United States and Canada, announced that Health Canada has approved KEYTRUDA SC™ (pembrolizumab injection), a new subcutaneous formulation of pembrolizumab,… Read More
